Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 672410, 9 pages
http://dx.doi.org/10.1155/2015/672410
Research Article

Interval Cancers in a Population-Based Screening Program for Colorectal Cancer in Catalonia, Spain

1Cancer Prevention and Control Program, Catalan Institute of Oncology, IDIBELL, L’Hospitalet de Llobregat, 08908 Barcelona, Spain
2Barcelona Health Region, CatSalut, 08023 Barcelona, Spain
3Consortium for Biomedical Research in Epidemiology and Public Health (CIBEResp), 28029 Madrid, Spain
4Department of Fundamental Care and Medical-Surgical Nursing, University of Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain
5Department of Clinical Sciences, University of Barcelona, L’Hospitalet de Llobregat, 08907 Barcelona, Spain

Received 9 December 2014; Revised 11 February 2015; Accepted 12 February 2015

Academic Editor: Bjørn Moum

Copyright © 2015 M. Garcia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, I. Soerjomataram, M. Ervik et al., GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base no. 11, International Agency for Research on Cancer, Lyon, France, 2013, http://globocan.iarc.fr/.
  2. Ø. Holme, M. Bretthauer, A. Fretheim, J. Odgaard-Jensen, and G. Hoff, “Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals,” The Cochrane Database of Systematic Reviews, vol. 9, Article ID CD009259, 2013. View at Google Scholar · View at Scopus
  3. L. Van Dam and M. Bretthauer, “Ethical issues in colorectal cancer screening,” Best Practice and Research: Clinical Gastroenterology, vol. 28, no. 2, pp. 315–326, 2014. View at Google Scholar · View at Scopus
  4. P. Hewitson, P. Glasziou, E. Watson, B. Towler, and L. Irwig, “Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update,” The American Journal of Gastroenterology, vol. 103, no. 6, pp. 1541–1549, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. B. J. Elmunzer, R. A. Hayward, P. S. Schoenfeld, S. D. Saini, A. Deshpande, and A. K. Waljee, “Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer; a systematic review and meta-analysis of randomized controlled trials,” PLoS Medicine, vol. 9, no. 12, Article ID e1001352, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. M. Gray, J. Patnick, and R. Blanks, “Maximising benefit and minimising harm of screening,” British Medical Journal, vol. 336, no. 7642, pp. 480–483, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. T. C. Prevost, G. Launoy, S. W. Duffy, and H. H. Chen, “Estimating sensitivity and sojourn time in screening for colorectal cancer: a comparison of statistical approaches,” The American Journal of Epidemiology, vol. 148, no. 6, pp. 609–619, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. M. H. E. Robinson, J. D. Hardcastle, S. M. Moss et al., “The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer,” Gut, vol. 45, no. 4, pp. 588–592, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Halloran, G. Launoy, and M. Zappa, “Evidence for the effectiveness of colorectal cancer screening,” in European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis, N. Segnan, J. Patnick, and L. von Karsa, Eds., European Commission, Publications Office of the European Union, 1st edition, 2010. View at Google Scholar
  10. S. G. Patel and D. J. Ahnen, “Prevention of interval colorectal cancers: what every clinician needs to know,” Clinical Gastroenterology and Hepatology, vol. 12, no. 1, pp. 7–15, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Pabby, R. E. Schoen, J. L. Weissfeld et al., “Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial,” Gastrointestinal Endoscopy, vol. 61, no. 3, pp. 385–391, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Robertson, D. Lieberman, S. J. Winawer et al., “795 interval cancer after total colonoscopy: results from a pooled analysis of eight studies,” Gastroenterology, vol. 134, no. 4, pp. 111–112, 2008. View at Publisher · View at Google Scholar
  13. S. M. Moss, J. D. Hardcastle, D. A. Coleman, M. H. E. Robinson, and V. C. Rodrigues, “Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test,” International Journal of Epidemiology, vol. 28, no. 3, pp. 386–390, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Ciatto, C. Naldoni, A. Ponti et al., “Interval carcinomas as indicators of screenig programme performance. Evaluation modalities and standards,” Epidemiologia & Prevenzione, vol. 32, pp. 93–99, 2008. View at Google Scholar
  15. M. G. Martínez, G. B. Rodríguez, N. M. Díaz et al., “Evaluating colorectal cancer screening strategies (immunological test vs biochemical test) in Catalonia, Spain 2008–2010,” Revista Española de Salud Pública, vol. 85, no. 6, pp. 593–602, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Hallifax, M. Lacey, P. Bevis, N. R. Borley, T. Brooklyn, and J. M. D. Wheeler, “Slipping through the bowel cancer screening programme,” Colorectal Disease, vol. 14, no. 7, pp. 844–847, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. Medical Advisory Secretariat, “Fecal occult blood test for colorectal cancer screening: an evidence-based analysis. Toronto, ON, Canada: Ontario Ministry of Health and Long-Term Care,” Ontario Health Technology Assessment Series, vol. 9, no. 10, pp. 1–40, 2009. View at Google Scholar
  18. J. Giai, C. Exbrayat, B. Boussat et al., “Sensitivity of a colorectal cancer screening program based on a guaiac test: a population-based study,” Clinics and Research in Hepatology and Gastroenterology, vol. 38, no. 1, pp. 106–111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Tazi, J. Faivre, C. Lejeune, P. Bolard, J. M. Phelip, and A. M. Benhamiche, “Interval cancers in a community-based programme of colorectal cancer screening with faecal occult blood test,” European Journal of Cancer Prevention, vol. 8, no. 2, pp. 131–135, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. M. D. Gill, M. G. Bramble, C. J. Rees, T. J. W. Lee, D. M. Bradburn, and S. J. Mills, “Comparison of screen-detected and interval colorectal cancers in bowel cancer screening programme,” British Journal of Cancer, vol. 107, no. 3, pp. 417–421, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. S. M. Moss, C. Campbell, J. Melia et al., “Performance measures in three rounds of the English bowel cancer screening pilot,” Gut, vol. 61, no. 1, pp. 101–107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. R. J. C. Steele, P. McClements, C. Watling et al., “Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site,” Gut, vol. 61, no. 4, pp. 576–581, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Zorzi, C. Fedato, G. Grazzini et al., “High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy,” Gut, vol. 60, no. 7, pp. 944–949, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Zappa, G. Castiglione, E. Paci et al., “Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the district of florence experience,” International Journal of Cancer, vol. 92, no. 1, pp. 151–154, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Launoy, T. C. Smith, S. W. Duffy, and V. Bouvier, “Colorectal cancer mass-screening: estimation of faecaloccult blood test sensitivity,taking into account cancer mean sojourn time,” International Journal of Cancer, vol. 73, no. 2, pp. 220–224, 1997. View at Publisher · View at Google Scholar
  26. W. Zheng and C. M. Rutter, “Estimated mean sojourn time associated with hemoccult sensa for detection of proximal and distal colorectal cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 21, no. 10, pp. 1722–1730, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. E. J. A. Morris, L. E. Whitehouse, T. Farrell et al., “A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS bowel cancer screening programme,” British Journal of Cancer, vol. 107, no. 5, pp. 757–764, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Paimela, N. Malila, T. Palva, T. Hakulinen, H. Vertio, and H. Järvinen, “Early detection of colorectal cancer with faecal occult blood test screening,” British Journal of Surgery, vol. 97, no. 10, pp. 1567–1571, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. M. Cid, I. V. Niñirola, M. D. C. López, J. T. Martínez, E. P. Sánchez, and C. N. Sánchez, “Validation of colorectal cancer diagnostic codes in a hospital administration data set,” Gaceta Sanitaria, vol. 20, no. 4, pp. 266–272, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. J. M. Richter, M. S. Pino, T. R. Austin et al., “Genetic mechanisms in interval colon cancers,” Digestive Diseases and Sciences, vol. 59, no. 9, pp. 2255–2263, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. A. L. Cisyk, H. Singh, and K. J. McManus, “Establishing a biological profile for interval colorectal cancer,” Digestive Diseases and Sciences, vol. 59, no. 10, pp. 2390–2402, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. M. A. Arain, M. Sawhney, S. Sheikh et al., “CIMP status of interval colon cancers: another piece to the puzzle,” The American Journal of Gastroenterology, vol. 105, no. 5, pp. 1189–1195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Shaukat, M. Arain, B. Thaygarajan, J. H. Bond, and M. Sawhney, “Is BRAF mutation associated with interval colorectal cancers?” Digestive Diseases and Sciences, vol. 55, no. 8, pp. 2352–2356, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Shaukat, M. Arain, R. Anway, S. Manaktala, L. Pohlman, and B. Thyagarajan, “Is KRAS mutation associated with interval colorectal cancers?” Digestive Diseases and Sciences, vol. 57, no. 4, pp. 913–917, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. J.-L. Bulliard, P. Sasieni, C. Klabunde, J.-P. de Landtsheer, B. C. Yankaskas, and J. Fracheboud, “Methodological issues in international comparison of interval breast cancers,” International Journal of Cancer, vol. 119, no. 5, pp. 1158–1163, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Sandelau, “Report of the Expert Working Group ‘Right-sided lesions & Interval CRCs’,” World Endoscopy Organization Colorectal Cancer Screening Committee Meeting, Chicago (EEUU), May 2014, http://worldendo.org/assets/downloads/pdf/resources/ccsc/2014/03_Sanduleanu_Right_sided_lesions_and_Interval_Cancers.pdf.
  37. R. Almazán, “Protocol proposal for the assessment of interval cancers in colorectal cancer screening programs,” in Proceedings of the 17th Annual Meeting of the Spanish Cancer Screening Network, Santiago de Compostela, Spain, June 2014, http://www.programascancerdemama.org/images/archivos/C_8_Protocolo_CI_CCR.pdf.